Home > Keywords >
| Catalog | name | Description | price |
|---|---|---|---|
| R-R-2458 | (R)-(-)-JQ1 Enantiomer CAS No.1268524-71-5 | (R)-(-)-JQ1 Enantiomer/CAS No.1268524-71-5 is the stereoisomer of (+)-JQ1. (+)-JQ1 potently decreases expression of both BRD4 target genes, whereas (R)-(-)-JQ1 Enantiomer has no effect. | price> |
| R-C-759 | LX1606 cas:1033805-22-9 | LX 1606 is an orally bioavailable,small-molecule,tryptophan hydroxylase(TPH) inhibitor with potential antiserotonergic activity. | price> |
| R-R-2459 | GNE-049 CAS No.1936421-41-8 | GNE-049/CAS No.1936421-41-8 is a highly potent and selective CBP inhibitor with an IC50 of 1.1 nM in TR-FRET assay. GNE-049 also inhibits BRET and BRD4(1) with IC50s of 12 nM and 4200 nM, respectively. | price> |
| R-C-760 | sgc0946 CAS No. 1561178-17-3 | SGC0946 is a highly potent and selective DOT1L methyltransferase inhibitor with IC50 of 0.3 nM;selectively kill mixed lineage leukaemia cells. | price> |
| R-R-2460 | FHT-1015 CAS No.2368903-18-6 | FHT-1205/CAS No.2368903-18-6 is a potent SMARCA4/SMARCA2 ATPase (BRG1 and BRM) inhibitor with IC50s of ≤10 nM (WO2020160180A1; compound 67). | price> |
| R-C-761 | SKLB1002 cas:1225451-84-2 | SKLB1002 is a new potent VEGFR2 inhibitor,which could significantly inhibit HUVEC proliferation,migration,invasion,and tube formation. | price> |
| R-R-2461 | GSK2801 CAS No.1619994-68-1 | GSK2801/CAS No.1619994-68-1 is a potent, selective, orally active and cell active acetyl-lysine competitive BAZ2A and BAZ2B bromodomains inhibitor with Kd values of 136 nM and 257 nM, respectively. GSK2801 shows >50-fold selectivity for BAZ2A/B over BRD4. | price> |
| R-C-762 | HS-173 cas:1276110-06-5 | HS-173,a novel phosphatidylinositol 3-kinase(PI3K)inhibitor,has anti-tumor activity through promoting apoptosis and inhibiting angiogenesis. | price> |
| R-R-2462 | BRD4 degrader AT1 CAS No.2098836-45-2 | BRD4 degrader AT1/CAS No.2098836-45-2 is a PROTAC connected by ligands for von Hippel-Lindau and BRD4 as a highly selective Brd4 degrader, with a Kd of 44 nM for Brd4BD2 in cells. | price> |
| R-C-763 | DAPT (GSI-IX, LY-374973) cas:208255-80-5 | DAPT(GSI-IX,LY-374973)is a novel γ-secretase inhibitor,which inhibits Aβ production with IC50 of 20 nM in HEK 293 cells.DAPT enhances the apoptosis of human tongue carcinoma cells and regulates autophagy. | price> |
| R-R-2463 | BAY-299 CAS No.2080306-23-4 | BAY-299/CAS No.2080306-23-4 is a very potent, dual inhibitor with IC50s of 67 nM for BRPF2 bromodomains (BD), 8 nM for TAF1 BD2, and 106 nM for TAF1L BD2. | price> |
| R-C-764 | CZC54252 CAS:1191911-27-9 | CZC54252 is a highly effective inhibitor of LRRK2.Its IC50 values for wild-type LRRK2 and mutant G2019S LRRK2 are 1.28 and 1.85 nm,respectively. | price> |
| R-R-2464 | FKBP12 PROTAC dTAG-7 CAS No.2064175-32-0 | FKBP12 PROTAC dTAG-7 (dTAG-7)/CAS No.2064175-32-0 is a heterobifunctional degrader. FKBP12 PROTAC dTAG-7 (dTAG-7) is a degrader of FKBP12F36V with expression of FKBP12F36V in-frame with a protein of interest. FKBP12 PROTAC dTAG-7 (dTAG-7) also is a selective degrader of BET bromodomain transcriptional co-activator BRD4 by bridging BET bromodomains to an E3 ubiquitin ligase CRBN. | price> |
| R-R-2465 | Trotabresib CAS No.1706738-98-8 | CC-90010 (compound 1)/CAS No.1706738-98-8 is a reversible and orally active BET inhibitor. CC-90010 is applied in the study for advanced solid tumors. | price> |
| R-R-2466 | Biotinylated-JQ1 CAS No.1635437-52-3 | Biotinylated-JQ1 (Biotin-JQ1)/CAS No.1635437-52-3 is a biotinylated derivative of JQ1 with high affinity for the bromodomain of BRD4. Biotinylated-JQ1 inhibits MM1.S multiple myeloma cells proliferation with the EC50 of 0.4 μM. | price> |
| R-R-2467 | A1874 CAS No.2064292-12-0 | A1874/CAS No.2064292-12-0 is a nutlin-based (MDM2 ligand) and BRD4-degrading PROTAC with a DC50 of 32 nM (induce BRD4 degradation in cells). Effective in inhibiting many cancer cell lines proliferation. | price> |
| R-R-2468 | SGC-SMARCA-BRDVIII CAS No.1997319-84-2 | SGC-SMARCA-BRDVIII/CAS No.1997319-84-2 is a potent and selective inhibitor of SMARCA2/4 and PB1(5), with Kds of 35 nM, 36 nM, and 13 nM, respectively. SGC-SMARCA-BRDVIII also inhibits PB1(2) and PB1(3), with Kds of 3.7 and 2.0 μM, respectively. SGC-SMARCA-BRDVIII can block adipogenesis of 3T3-L1 murine fibroblasts. | price> |
| R-R-2469 | (+)-JQ1 PA CAS No.2115701-93-2 | (+)-JQ1 PA/CAS No.2115701-93-2 is a derivative of the Bromodomain and extra-terminal (BET) inhibitor JQ1, with an IC50 of 10.4 nM. (+)-JQ1 PA is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups. | price> |
| R-R-2470 | MI-463 CAS No.1628317-18-9 | MI-463/CAS No.1628317-18-9 is a highly potent and orally bioavailable small molecule inhibitor of the menin-mLL interaction. | price> |
| R-R-2471 | GSK 4027 CAS No.2079896-25-4 | GSK 4027/CAS No.2079896-25-4 is a chemical probe for the PCAF/GCN5 bromodomain with an pIC50 of 7.4±0.11 for PCAF in a time-resolved fluorescence resonance energy transfer (TR-FRET) assay. | price> |

Items-$0.00

Email:
Tel.:
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


